Schmidt, Morten

Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the Working Group for Cardiovascular Pharmacotherapy of the European Society of Cardiology

Schmidt, M., Lamberts, M., Olsen, A.-M. S., Fosbøll, E., Niessner, A., Tamargo, J., Rosano, G., Agewall, S., Kaski, J. C., Kjeldsen, K., et al. (2016) · European Heart Journal

Inflammatory mediators and NSAID effectsAntiplatelet Therapy and Cardiovascular Diseases

Cited by 164

Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study

Schmidt, M., Mansfield, K. E., Bhaskaran, K., Nitsch, D., Sørensen, H. T., Smeeth, L., & Tomlinson, L. A. (2017) · BMJ

Chronic Kidney Disease and DiabetesRenin-Angiotensin System Studies

Cited by 157

Effectiveness of Empagliflozin vs Dapagliflozin for Kidney Outcomes in Type 2 Diabetes

Bonnesen, K., Heide-Jørgensen, U., Christensen, D. H., Christiansen, C. F., Lash, T. L., Hennessy, S., Matthews, A. A., Pedersen, L., Thomsen, R. W., & Schmidt, M. (2025) · JAMA Internal Medicine

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 17

Cohort Profile: Better Health in Late Life

Sørensen, H., Christensen, T., Bøtker, H. E., Christiansen, C., Fuglsang, C., Gribsholt, S., Kristensen, F., Laugesen, K., Laursen, A., Nørgaard, M., et al. (2023) · Clinical Epidemiology

Chronic Disease Management StrategiesPharmaceutical Practices and Patient Outcomes

Cited by 7